2019 CMHC West - Virtual Exhibit Hall
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information visit www.amarincorp.com.
ASEPA is the official constituent chapter of the American Academy of Physician Assistants (AAPA) representing PAs in the specialty of Endocrinology.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Med Learning Group’s mission is to design educational activities for healthcare practitioners that increase competence, change behavior and optimize patient care. The focus of our education is to create innovative and interactive educational programs designed with scientific rigor, fair balance and evidence-based content.
MLG emphasizes collaboration with academic and community-based hospitals, government agencies, medical associations, managed care organizations and other important stakeholders in the healthcare industry in order to provide pertinent educational activities that fill the educational gap for our relevant target audiences.
MLG develops programming in a multitude of areas including oncology, neurology, psychiatry, infectious disease, immunology, cardiovascular, respiratory, ophthalmology and transplant. These programs are designed in both live and enduring formats with special attention paid to interactivity and innovation.
Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market Medicure's vision is to become a leading cardiovascular pharmaceutical company within the U.S, offering a growing product portfolio of cardiovascular products that improve patients' lives. We have an unwavering focus on delivering safe, efficacious and cost-effective medicines that benefit patients, healthcare providers and shareholders. Our commitment to service, partnership and integrity is what sets us apart.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers, students, and the next generation of healthcare providers. With a focus on clinical effectiveness, research and learning, safety and surveillance, and interoperability and data intelligence, our proven solutions drive effect decision-making and consistent outcomes across the continuum of care.